$Redhill Biopharma(RDHL.US)$RedHill Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Study Of RHB-107 (Upamostat), The Study Is Expected To Be Completed By The End Of 2024
RedHill Biopharma's New Patent: A Potential Game-Changer in the Fight Against Coronavirus. In a significant development in the medical community, RedHill Biopharma Ltd ($RDHL) has been granted US patent number 11,918,560, titled "Serine Protease Inhibitor for Treating Coronavirus Infection". The implications of this breakthrough could be far-reaching, potentially reshaping our approach to managing and treating coronavirus infections.$Redhill Biopharma(RDHL.US)$ ...
$Redhill Biopharma(RDHL.US)$Redhill Biopharma And Apogee Biotechnology's Opaganib Selected By U.S. Government's Chemical Medical Countermeasures Program And Chemical Countermeasures Research Program For A Potential Medical Countermeasure Against Inhalation Sulfur Mustard Exposure
$Redhill Biopharma(RDHL.US)$RedHill Biopharma Will Be Issued U.S. Patent Number 11,918,560 Tomorrow Titled "Serine Protease Inhibitor For Treating Coronavirus Infection"
4
19
举报
DarthTrader069 :
I had high hopes for this awhile back. It's on my watch list. It's beaten down
Trytosaveabit楼主DarthTrader069:
Yes it is! It’s a shame to! With the 5 year exclusive on the one antibiotic! And another in phase 2 with the backing of the US Army! And other things! Yeah I dig it! But damn SS’s! Hehehe
Redhill Biopharma股票讨论区
Update
RedHill Biopharma Ltd., a specialty biopharmaceutical company, announced on March 11, 2024, that the U.S. Patent and Trademark Office (USPTO) has issued a new patent for Talicia,
Finally, let’s double up!
Build that base and take off, I’m ready
Medical Company Receives New Patent For COVID-19 Drug
In a significant development in the medical community, RedHill Biopharma Ltd ($RDHL) has been granted US patent number 11,918,560, titled "Serine Protease Inhibitor for Treating Coronavirus Infection". The implications of this breakthrough could be far-reaching, potentially reshaping our approach to managing and treating coronavirus infections. $Redhill Biopharma(RDHL.US)$
...
News not power enough
Good news, now run!
Update
Hmm? We will see? Hehehe
暂无评论